— Perrigo Company plc (NYSE: PRGO) reported Q3 2019 earnings of $1.04 per share, vs. $0.93 expected.
— Sales grew 5.1% to $1.2 billion, vs. $1.2 billion expected.
— Worldwide Consumer net sales increased 3.3% to $961 million.
— Prescription Pharmaceuticals sales improved 13.6% to $230 million.
— FY19 GAAP EPS is expected to be $2.01-2.21.
— FY19 adjusted EPS is expected to be $3.85-4.05.
— PRGO shares gained 0.98% following the announcement.
Get access to timely and accurate verbatim transcripts that are published within hours of the event.
Most Popular
CCL Earnings: Highlights of Carnival Corporation’s Q4 2025 results
Cruise operator Carnival Corporation & plc (NYSE: CCL) on Friday reported an increase in revenue and adjusted earnings for the fourth quarter of fiscal 2025. Earnings topped analysts' expectations. Revenues
Lamb Weston (LW) Q2 2026 Earnings: Key financials and quarterly highlights
Lamb Weston Holdings, Inc. (NYSE: LW) reported its second quarter 2026 earnings results today. Net sales inched up 1% year-over-year to $1.62 billion. Net sales at constant currency remained flat.
Paychex reports higher Q2 FY26 revenue and earnings; EPS beats estimates
Paychex Inc. (NASDAQ: PAYX) on Friday reported stronger-than-expected adjusted earnings for the second quarter of fiscal 2026. Revenues grew 18% year-over-year. The Rochester-based human capital management solutions provider reported revenues
